Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Collaboration On Foreign Inspections Helps FDA Improve Resource Allocations

This article was originally published in The Tan Sheet

Executive Summary

FDA better allocated resources for foreign inspections based on information European and Australian authorities shared in a two-year pilot program, including conducting good manufacturing practices inspections that met the needs of multiple agencies.

You may also be interested in...



FDA Closing Office In Jordan To Better Leverage Shrinking Resources

Opened as part of the globalization initiative, FDA’s presence in the Middle East and North Africa will shut down in late December in an apparent cost-cutting effort.

FDA Closing Office In Jordan To Better Leverage Shrinking Resources

Opened as part of the globalization initiative, FDA’s presence in the Middle East and North Africa will shut down in late December in an apparent cost-cutting effort.

FDA Could Publish Drug GMP Data To Nudge Manufacturing Improvements

Batch failure and other measures manufacturers commonly track could be aggregated into an industry-wide index FDA would use to help make inspection decisions. CDER compliance chief Howard Sklamberg says FDA wants more predictive measures to find quality issues, rather than lagging metrics such as recalls or adverse events.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS105235

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel